David Reddy

MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland.

Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012.

The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024.